These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20457820)

  • 1. Emergence of resistant Klebsiella pneumoniae in the intestinal tract during successful treatment of Klebsiella pneumoniae lung infection in rats.
    Kesteman AS; Perrin-Guyomard A; Laurentie M; Sanders P; Toutain PL; Bousquet-Mélou A
    Antimicrob Agents Chemother; 2010 Jul; 54(7):2960-4. PubMed ID: 20457820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence and acquisition of fluoroquinolone-resistant gram-negative bacilli in the intestinal tracts of mice treated with fluoroquinolone antimicrobial agents.
    Pultz MJ; Nerandzic MM; Stiefel U; Donskey CJ
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3457-60. PubMed ID: 18606843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
    Lee K; Park KH; Jeong SH; Lim HS; Shin JH; Yong D; Ha GY; Chong Y; KONSAR group
    Yonsei Med J; 2006 Feb; 47(1):43-54. PubMed ID: 16502484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low or high doses of cefquinome targeting low or high bacterial inocula cure Klebsiella pneumoniae lung infections but differentially impact the levels of antibiotic resistance in fecal flora.
    Vasseur MV; Laurentie M; Rolland JG; Perrin-Guyomard A; Henri J; Ferran AA; Toutain PL; Bousquet-Mélou A
    Antimicrob Agents Chemother; 2014; 58(3):1744-8. PubMed ID: 24395228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model.
    Kesteman AS; Ferran AA; Perrin-Guyomard A; Laurentie M; Sanders P; Toutain PL; Bousquet-Mélou A
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4740-8. PubMed ID: 19738020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae.
    Caballero S; Carter R; Ke X; Sušac B; Leiner IM; Kim GJ; Miller L; Ling L; Manova K; Pamer EG
    PLoS Pathog; 2015 Sep; 11(9):e1005132. PubMed ID: 26334306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
    Lepak AJ; Andes DR
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection.
    Goessens WH; Mouton JW; ten Kate MT; Bijl AJ; Ott A; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2007 Mar; 59(3):507-16. PubMed ID: 17289765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy.
    Lautenbach E; Metlay JP; Bilker WB; Edelstein PH; Fishman NO
    Clin Infect Dis; 2005 Oct; 41(7):923-9. PubMed ID: 16142655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of fluoroquinolone resistance in Klebsiella.
    Yang YL; Lauderdale TL; Lo HJ
    Curr Drug Targets Infect Disord; 2004 Dec; 4(4):295-302. PubMed ID: 15578970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of antimicrobial resistance plasmids from Klebsiella pneumoniae to Escherichia coli in the mouse intestine.
    Schjørring S; Struve C; Krogfelt KA
    J Antimicrob Chemother; 2008 Nov; 62(5):1086-93. PubMed ID: 18703526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.
    Bolon MK; Wright SB; Gold HS; Carmeli Y
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1934-40. PubMed ID: 15155181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolone resistance in Escherichia coli and Klebsiella pneumoniae over 18 years: effect of different systems for eliminating duplicates.
    Noguera O; López-Riquelme N; Rodríguez JC; Belda S; Galiana A; Ruiz-García M; López-García P; Royo G
    J Antimicrob Chemother; 2011 Sep; 66(9):2182-4. PubMed ID: 21693462
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro Activity of Sitafloxacin and Other Antibiotics against Bacterial Isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital.
    Tantisiriwat W; Linasmita P
    J Med Assoc Thai; 2017 Apr; 100(4):469-78. PubMed ID: 29912484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections.
    Lautenbach E; Fishman NO; Bilker WB; Castiglioni A; Metlay JP; Edelstein PH; Strom BL
    Arch Intern Med; 2002 Nov; 162(21):2469-77. PubMed ID: 12437407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Antibiotic-Resistant Bacteria on Immune Activation and Clostridioides difficile Infection in the Mouse Intestine.
    Keith JW; Dong Q; Sorbara MT; Becattini S; Sia JK; Gjonbalaj M; Seok R; Leiner IM; Littmann ER; Pamer EG
    Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31907198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic-Driven Dysbiosis Mediates Intraluminal Agglutination and Alternative Segregation of Enterococcus faecium from the Intestinal Epithelium.
    Hendrickx AP; Top J; Bayjanov JR; Kemperman H; Rogers MR; Paganelli FL; Bonten MJ; Willems RJ
    mBio; 2015 Nov; 6(6):e01346-15. PubMed ID: 26556272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study.
    Demonchy E; Courjon J; Ughetto E; Durand M; Risso K; Garraffo R; Roger PM
    Int J Antimicrob Agents; 2018 Jun; 51(6):836-841. PubMed ID: 29378342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enlisting commensal microbes to resist antibiotic-resistant pathogens.
    Keith JW; Pamer EG
    J Exp Med; 2019 Jan; 216(1):10-19. PubMed ID: 30309968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.